The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kholin A.A.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Voronkova K.V.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Pylaeva O.A.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Petrukhin A.S.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Efficacy and safety of intravenous valproates

Authors:

Kholin A.A., Voronkova K.V., Pylaeva O.A., Petrukhin A.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(3‑2): 55‑59

Read: 2783 times

Download PDF (RU)
Contact the author
Table of contents

EFFICACY AND SAFETY OF INTRAVENOUS VALPROATES
EFFICACY AND SAFETY OF INTRAVENOUS VALPROATES

To cite this article:

Kholin AA, Voronkova KV, Pylaeva OA, Petrukhin AS. Efficacy and safety of intravenous valproates. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(3‑2):55‑59. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Keywords:

status epilepticus
antiepileptic treatment
intravenous valproate (convulex)

Authors:

Kholin A.A.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Voronkova K.V.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Pylaeva O.A.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Petrukhin A.S.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Close metadata

References:

  1. Evtushenko S.K., Golubeva I.N., Prokhorova L.M. i dr. Vnutrivennaya forma konvuleksa kak effektivnoe sredstvo pri uchashchenii epilepticheskikh pristupov i predstatusnykh sostoyaniyakh u mladentsev i detei. Mezhdunar nevrol zhurn 2009;5:27:84-88.
  2. Karlov V.A., Andreeva O.V. Primenenie in''ektsionnogo depakina pri lechenii epilepticheskogo statusa. Rus med zhurn 2001;20:9:889-893.
  3. Karlov V.A. Poshagovaya terapiya epilepticheskogo statusa. Obshchie rekomendatsii po dozam i skhemam vvedeniya. M 2009;3.
  4. Agarwal P., Kumar N., Chandra R. et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007;16:6:527-532.
  5. Bourgeois J.A., Koike A.K., Simmons J.E. et al. Adjunctive valproic acid for delirium and/or agitation on a consultation-liaison service: a report of six cases. J Neuropsychiat Clin Neurosci 2005;17:2:232-238.
  6. DeLorenzo R.J., Hauser W.A., Towne A.R. et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-1035.
  7. Devinsky O., Leppik I.,Willmore L.J. et al. Safety of intravenous valproate. Ann Neurol 1995;38:670-674.
  8. DeWolfe J.L., Knowlton R.C., Beasley M.T. et al. Hyperammonemia following intravenous valproate loading. Epilepsy Res 2009;85:1:65-71.
  9. Edwards K.R., Norton J., Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001;41:10:976-980.
  10. Grunze H., Erfurth A., Amann B. et al. Intravenous valproate loading in acutely manic and depressed bipolar I patients. J Clin Psychopharmacol 1999;19:4:303-309.
  11. Hauser W.A. Status epilepticus: epidemiologic considerations. Neurology 1990;40:Suppl 2:9-13.
  12. Hilty D.M., Rodriguez G.D., Hales R.E. Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders. J Neuropsychiat Clin Neurosci 1998;10:3:365-366.
  13. Hovinga C.A., Chicella M.F., Rose D.F. et al. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother 1999;33:5:579-584.
  14. Kanner A.M. Intravenous valproate for status epilepticus ... An effective, yet still merely empirical alternative. Epilepsy Curr 2008;8:3:66-67.
  15. Leniger T., Pageler L., Stude P. et al. Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks. Headache 2005;45:1:42-46.
  16. Limdi N.A., Shimpi A.V., Faught E. et al. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005;64:353-355.
  17. Limdi N.A., Knowlton R.K., Cofield S.S. et al. Safety of rapid intravenous loading of valproate. Epilepsia 2007;48:3:478-483.
  18. Morton L.D., O’Hara K.A., Coots B.P., Pellock J.M. Safety of rapid intravenous valproate infusion in pediatric patients. Pediat Neurol 2007;36:2:81-83.
  19. Naritoku D.K., Mueed S. Intravenous loading of valproate for epilepsy. Clin Neuropharmacol 1999;22:2:102-106.
  20. Norton J.W. The use of intravenous valproate in acute mania. Gen Hosp Psychiat 2000;22:5:389-391.
  21. Norton J.W. Use of intravenous valproate sodium in status migraine. Headache 2000;40:9:755-757.
  22. Peters C.N., Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus - experience in 102 adult patients. Seizure 2005:14:164-169.
  23. Qalbani M., De León O.A. Intravenous valproate treatment of uncontrollable aggression: a case report. J Clin Psychopharmacol 2007;27:5:529-531.
  24. Ramsay R.E., Uthman B., Leppik I.E. The tolerability and safety of valproate sodium injection given as an intravenous infusion. J Epilepsy 1997;10:187-193.
  25. Ramsay R.E., Cantrell D., Collins S.D. et al. Safety and tolerance of rapidly infused Depacon. A randomized trial in subjects with epilepsy. Epilepsy Res 2003;52:189-201.
  26. Ranjan S., Jagadheesan K., Nizamie S.H. Cerebellar ataxia with intravenous valproate and haloperidol. Aust N Z J Psychiat 2002;36:2:268.
  27. Regenold W.T., Prasad M. Uses of intravenous valproate in geriatric psychiatry. Am J Geriat Psychiat 2001;9:3:306-308.
  28. Schwartz T.H., Karpitskiy V.V., Sohn R.S. Intravenous valproate sodium in the treatment of daily headache. Headache 2002;42:6:519-522.
  29. Semion K., Dorsey J., Bourgeois J. Intravenous valproate use in bipolar II disorder after gastric bypass surgery. J Neuropsychiat Clin Neurosci 2005;17:3:427-429.
  30. Shorvon S.D. Status epilepticus: its clinical features and treatment in children and adults. Cambridge: Cambridge University Press 1994.
  31. Tadke R.R., Suryavanshi P. Use of intravenous valproate in a patient with neuroleptic malignant syndrome. J Neuropsychiat Clin Neurosci 2006;18:1:131-132.
  32. Tiamkao S., Sawanyawisuth K. Predictors and prognosis of status epilepticus treated with intravenous sodium valproate. Epileptic Dis 2009;11:3:228-231.
  33. Thakur A., Dutta S., Sinha V.K. Intravenous valproate in acute adolescent mania: a preliminary report. Eur Child Adolesc Psychiat 2004;13:4:258-261.
  34. Thomaides T., Karapanayiotides T., Kerezoudi E. et al. Intravenous valproate aborts glyceryl trinitrate-induced migraine attacks: a clinical and quantitative EEG study. Cephalalgia 2008;28:3:250-256.
  35. Treiman D.M. Generalized convulsive status epilepticus. In: Status epilepticus: mechanisms and management. 1st ed. Eds. C.L. Wasterlain, D.M. Treiman. Boston: MIT Press 2006;55-68.
  36. Uberall M.A., Trollmann R., Wunsiedler U., Wenzel D. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 2000;54:2188-2189.
  37. Venkataraman V., Wheless J.W. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 1999;35:147-153.
  38. Waberzinek G., Marková J., Mastík J. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine. Neurol Endocrinol Lett 2007;28:1:59-64.
  39. Wheless J.W., Venkataraman V. Safety of high intravenous valproate loading in epilepsy patients. J Epilepsy 1998;11:319-324.
  40. Wheless J.W., Vazquez B.R., Kanner A.M. et al. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004;63:1507-1508.
  41. Yu K.T., Mills S., Thompson N., Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 2003;44:724-726.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.